Appeal or third-party opposition 03-01-2025Filing the claim in RegSol 11-01-2025First verification report 23-01-2025Late claim 12-12-2025
The trustee is Clementine Malschalck. The judgment is more than a year old. A claim can no longer be filed, not even late. The trustee knows whether anything will still be paid out.
Lifetime
3 annual accounts with figures on one time axis
peak of €6,624 in 2021
-€4,979▲ €210
lowest -€42,774 in 2023
-€42,774▼ €25,590
peak of €219,001 in 2022
€153,931▼ 29.7%
€54,093▼ 43.8%
Board3 names since 2021
3 directorsName after signing inVisible after signing in and 2 others
Documentsfilings and deeds
02-08-20242 days late
2023micro format
Loss of €42,7741 director resigning15-12Equity from €219,001 to €153,931Debts from €96,200 to €54,093Cash from €57,166 to €5,353
Key points
from the 2023 annual accounts, the last ones filed
1 director resigningName hiddenVisible after signing in (daily management delegate) · Hidden nameVisible after signing in and Name after signing inVisible after signing in act as permanent representatives · Board meeting of 29-11-2023 · Gazette deed
Capital contribution of €108,000
Capital contribution: apport supplémentaire en numéraire · General meeting of 01-02-2022 · Gazette deed
According to the KBO register, the main activity of the establishment unit is research and development on biotechnology (NACE 72101). The KBO lists 1 more.
What is the legal form of MitralShape?
MitralShape is a private limited company (BV).
When was MitralShape founded?
MitralShape was founded on 16-06-2021.
Is MitralShape still active?
A bankruptcy is running. A bankruptcy trustee manages the company.
What is the turnover of MitralShape?
The annual accounts for financial year 2023 state no turnover. The micro format does not require it.Financials
Is MitralShape profitable?
In financial year 2023, MitralShape made a loss of €42,774.
Where can I find the annual accounts of MitralShape?
MitralShape filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2023.